Search filters

List of works by Inge Juul Sørensen

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

scientific article published on 4 May 2017

Circulating levels of interleukin-6, vascular endothelial growth factor, YKL-40, matrix metalloproteinase-3, and total aggrecan in spondyloarthritis patients during 3 years of treatment with TNFα inhibitors

article by Susanne J. Pedersen et al published 18 July 2010 in Clinical Rheumatology

Response to ''To switch or not to switch': the missing piece in the puzzle of biosimilar literature?' by Scherlinger et al

scientific article published on 23 January 2019

Response to: 'Mandatory, cost-driven switching from originator etanercept to its biosimilar SB4: possible fallout on non-medical switching' by Cantini and Benucci

scientific article published on 20 December 2018

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

scientific article published on 05 November 2018

Paulina is supported by:

About Paulina

Help